glp-1 news nov 2025 today november 6 Nutritional priorities to support therapy for obesity: A joint advisory from the American College of Lifestyle Medicare's New GLP-1 Pricing Initiative

(2022, 2023) illustrated that AVN-C protects C57BL/6 mice from SNHL induced by the anti-cancer drugs methotrexate and cisplatin

The Deeper Cost of Weight Stigma Weight stigma isnt just hurtfulits harmful

Semaglutide reprograms macrophages via the GLP-1R/PPARG/ACSL1 pathway to suppress papillary thyroid carcinoma growth

Cortisol naturally rises and falls in concert with the circadian rhythm, but a bad day at work, relationship difficulties or even staring at an electronic screen for hours can cause unhealthy spikes in stress hormone that can keep you up and alert (and usually with your mind racing) for hours

Participants experienced significant reductions in both HbA1c levels and body weight, demonstrating the potential of cagrilintide and semaglutide as a powerful duo in weight management

The global market for obesity therapeutics has undergone a seismic shift, what does that mean for strategic GLP-1 dealmaking